[
  {
    "ts": null,
    "headline": "RBC Capital Initiates Coverage of Bristol-Myers Squibb (BMY) with Sector Perform Recommendation",
    "summary": "RBC Capital Initiates Coverage of Bristol-Myers Squibb (BMY) with Sector Perform Recommendation",
    "url": "https://finnhub.io/api/news?id=a7e15b1dfa9e7a2cb2294d0c87508465ce04d17faf6b1aa4adb4c557b6cc4d5f",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772049807,
      "headline": "RBC Capital Initiates Coverage of Bristol-Myers Squibb (BMY) with Sector Perform Recommendation",
      "id": 139224411,
      "image": "",
      "related": "BMY",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=a7e15b1dfa9e7a2cb2294d0c87508465ce04d17faf6b1aa4adb4c557b6cc4d5f"
    }
  },
  {
    "ts": null,
    "headline": "CYTK Posts a Wider-Than-Expected Q4 Loss, Advances Myqorzo Launch Plans",
    "summary": "CYTK reports a wider-than-expected Q4 loss as expenses rise, but Myqorzo wins FDA nod and global expansion advances, with $1.22B cash fueling 2026 catalysts.",
    "url": "https://finnhub.io/api/news?id=5fc837c231df1ccdd50bcb57f301d770e26fa47b655f0318f6ec5b109037ee3f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772044980,
      "headline": "CYTK Posts a Wider-Than-Expected Q4 Loss, Advances Myqorzo Launch Plans",
      "id": 139224044,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "CYTK reports a wider-than-expected Q4 loss as expenses rise, but Myqorzo wins FDA nod and global expansion advances, with $1.22B cash fueling 2026 catalysts.",
      "url": "https://finnhub.io/api/news?id=5fc837c231df1ccdd50bcb57f301d770e26fa47b655f0318f6ec5b109037ee3f"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock",
    "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
    "url": "https://finnhub.io/api/news?id=8b4d06d03a608c743c8484b1005d9468720d18e5dd71f3ab2a50dff34e468cfa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772030403,
      "headline": "Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock",
      "id": 139215610,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.",
      "url": "https://finnhub.io/api/news?id=8b4d06d03a608c743c8484b1005d9468720d18e5dd71f3ab2a50dff34e468cfa"
    }
  },
  {
    "ts": null,
    "headline": "5 Very Safe High-Yield Dividend Stocks Boomers Can Hold Forever",
    "summary": "While many Baby Boomers have enjoyed a long bull market over the past 35 years, there is a point when income becomes more critical than stock appreciation. The reason is simple: those who leave their careers to enjoy a well-deserved retirement lose the benefits of a regular salary and their jobs, such as 401(k) matching ... 5 Very Safe High-Yield Dividend Stocks Boomers Can Hold Forever",
    "url": "https://finnhub.io/api/news?id=76f4864efcde1ecc679b31f001655678bd113af2e2a7ffeb058ef2f5a2db9985",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772028991,
      "headline": "5 Very Safe High-Yield Dividend Stocks Boomers Can Hold Forever",
      "id": 139210636,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "While many Baby Boomers have enjoyed a long bull market over the past 35 years, there is a point when income becomes more critical than stock appreciation. The reason is simple: those who leave their careers to enjoy a well-deserved retirement lose the benefits of a regular salary and their jobs, such as 401(k) matching ... 5 Very Safe High-Yield Dividend Stocks Boomers Can Hold Forever",
      "url": "https://finnhub.io/api/news?id=76f4864efcde1ecc679b31f001655678bd113af2e2a7ffeb058ef2f5a2db9985"
    }
  },
  {
    "ts": null,
    "headline": "NYSE Content Update: Two MSCI Indexes to Begin Trading on NYSE Arca Options",
    "summary": "The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.",
    "url": "https://finnhub.io/api/news?id=fc8f4318c6e92f3692183f0cd3988e7fd227c67f7ccda71dbeddc5ac595c3775",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772027700,
      "headline": "NYSE Content Update: Two MSCI Indexes to Begin Trading on NYSE Arca Options",
      "id": 139207594,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.",
      "url": "https://finnhub.io/api/news?id=fc8f4318c6e92f3692183f0cd3988e7fd227c67f7ccda71dbeddc5ac595c3775"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Stock: Is PFE Underperforming the Healthcare Sector?",
    "summary": "Due to Pfizer’s underperformance relative to the healthcare sector over the past year, Wall Street analysts remain cautious about the stock’s prospects",
    "url": "https://finnhub.io/api/news?id=3aec763cb04db56053be7003d0feb211c1637b8dd15823f541cbc2c5e0e33672",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772025997,
      "headline": "Pfizer Stock: Is PFE Underperforming the Healthcare Sector?",
      "id": 139215591,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "Due to Pfizer’s underperformance relative to the healthcare sector over the past year, Wall Street analysts remain cautious about the stock’s prospects",
      "url": "https://finnhub.io/api/news?id=3aec763cb04db56053be7003d0feb211c1637b8dd15823f541cbc2c5e0e33672"
    }
  },
  {
    "ts": null,
    "headline": "Oruka Therapeutics: A Potential Future Psoriasis Play",
    "summary": "Oruka Therapeutics: A Potential Future Psoriasis Play",
    "url": "https://finnhub.io/api/news?id=20fd663d56461d661f04230d74318f359bae608478fd3016a1ee3b0648a05e09",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1772013790,
      "headline": "Oruka Therapeutics: A Potential Future Psoriasis Play",
      "id": 139209740,
      "image": "",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=20fd663d56461d661f04230d74318f359bae608478fd3016a1ee3b0648a05e09"
    }
  }
]